Analysts Advise Buy on Paytm, DLF, Manappuram, Blue Star; Sell Cipla, Dr Reddy's

• Somil Mehta of Mirae Asset Sharekhan recommends buying Paytm (target ₹1,440, SL ₹1,285) and DLF (target ₹750, SL ₹685).
• Mitessh Thakkar of Bonanza Portfolio suggests selling Cipla (target ₹1,420, SL ₹1,492) and Dr Reddy’s Laboratories (target ₹1,205, SL ₹1,260.50).
• Thakkar also advises buying Manappuram Finance (target ₹330-₹332, SL ₹317) and Blue Star (target ₹1,890, SL ₹1,840).
• Recommendations include clear stop losses and upside/downside targets for retail investors.
• The article includes a disclaimer that investment tips are experts' own views, not CNBCTV18.com's.

Why It Matters: Analysts recommend buying Paytm, DLF, Manappuram, Blue Star; selling Cipla, Dr Reddy's with targets.